Akums Drugs and Pharmaceuticals Limited
AKUMS
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Sept 2026395
Quarter ₹ crore YoY Sept 2024 328 — Dec 2024 337 — Mar 2025 329 — Jun 2025 332 +4.8% Sept 2025 309 -5.8% Dec 2025 369 +9.2% Mar 2026 338 +2.9% Jun 2026 392 +18.0% Sept 2026 395 +27.7% - ₹ crore
Sept 202626
Quarter ₹ crore Sept 2024 32 Dec 2024 34 Mar 2025 32 Jun 2025 29 Sept 2025 27 Dec 2025 30 Mar 2026 28 Jun 2026 26 Sept 2026 26 - ₹ crore
Sept 2026421
Quarter ₹ crore Sept 2024 360 Dec 2024 371 Mar 2025 361 Jun 2025 361 Sept 2025 336 Dec 2025 398 Mar 2026 366 Jun 2026 418 Sept 2026 421 - Cost structure
- ₹ crore
Sept 202665
Quarter ₹ crore Sept 2024 50 Dec 2024 50 Mar 2025 54 Jun 2025 51 Sept 2025 55 Dec 2025 55 Mar 2026 58 Jun 2026 59 Sept 2026 65 - ₹ crore
Sept 2026377
Quarter ₹ crore Sept 2024 299 Dec 2024 316 Mar 2025 324 Jun 2025 301 Sept 2025 305 Dec 2025 359 Mar 2026 342 Jun 2026 359 Sept 2026 377 - Exceptional items and tax
- ₹ crore
Sept 202644
Quarter ₹ crore Sept 2024 62 Dec 2024 55 Mar 2025 37 Jun 2025 60 Sept 2025 31 Dec 2025 36 Mar 2026 22 Jun 2026 59 Sept 2026 44 - ₹ crore
Sept 202611
Quarter ₹ crore Sept 2024 11 Dec 2024 14 Mar 2025 9 Jun 2025 15 Sept 2025 8 Dec 2025 8 Mar 2026 7 Jun 2026 14 Sept 2026 11 - Profit
- ₹ crore
Sept 202633
Quarter ₹ crore YoY Sept 2024 50 — Dec 2024 41 — Mar 2025 28 — Jun 2025 45 +7.1% Sept 2025 23 -53.4% Dec 2025 28 -31.7% Mar 2026 15 -44.9% Jun 2026 45 -0.1% Sept 2026 33 +39.1% - Per share
- ₹ per share
Sept 20262.13
Quarter ₹ per share Sept 2024 3.38 Dec 2024 2.69 Mar 2025 1.80 Jun 2025 2.93 Sept 2025 1.53 Dec 2025 1.84 Mar 2026 0.99 Jun 2026 2.93 Sept 2026 2.13 - Leverage
Debt to equity
timesSept 20240.00x
Quarter times Sept 2024 0.00x Dec 2024 — Mar 2025 — Jun 2025 — Sept 2025 — Dec 2025 — Mar 2026 — Jun 2026 — Sept 2026 —
| ₹ crore | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 328 | 337 | 329 | 332 | 309 | 369 | 338 | 392 | 395 | |
| Revenue YoY | — | — | — | +4.8% | -5.8% | +9.2% | +2.9% | +18.0% | +27.7% |
| 32 | 34 | 32 | 29 | 27 | 30 | 28 | 26 | 26 | |
| 360 | 371 | 361 | 361 | 336 | 398 | 366 | 418 | 421 | |
| Cost structure | |||||||||
| 50 | 50 | 54 | 51 | 55 | 55 | 58 | 59 | 65 | |
| 299 | 316 | 324 | 301 | 305 | 359 | 342 | 359 | 377 | |
| Exceptional items and tax | |||||||||
| 62 | 55 | 37 | 60 | 31 | 36 | 22 | 59 | 44 | |
| 11 | 14 | 9 | 15 | 8 | 8 | 7 | 14 | 11 | |
| Profit | |||||||||
| 50 | 41 | 28 | 45 | 23 | 28 | 15 | 45 | 33 | |
| Net profit YoY | — | — | — | +7.1% | -53.4% | -31.7% | -44.9% | -0.1% | +39.1% |
| Per share | |||||||||
| 3.38 | 2.69 | 1.80 | 2.93 | 1.53 | 1.84 | 0.99 | 2.93 | 2.13 | |
| Leverage | |||||||||
| Debt to equity | 0.00x | — | — | — | — | — | — | — | — |
Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.